» Articles » PMID: 22198976

Surfactant Protein-D Regulates Effector Cell Function and Fibrotic Lung Remodeling in Response to Bleomycin Injury

Overview
Specialty Critical Care
Date 2011 Dec 27
PMID 22198976
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: Surfactant protein (SP)-D and SP-A have been implicated in immunomodulation in the lung. It has been reported that patients with idiopathic pulmonary fibrosis (IPF) often have elevated serum levels of SP-A and SP-D, although their role in the disease is not known.

Objectives: The goal of this study was to test the hypothesis that SP-D plays an important role in lung fibrosis using a mouse model of fibrosis induced by bleomycin (BLM).

Methods: Triple transgenic inducible SP-D mice (iSP-D mice), in which rat SP-D is expressed in response to doxycycline (Dox) treatment, were administered BLM (100 U/kg) or saline subcutaneously using miniosmotic pumps.

Measurements And Main Results: BLM-treated iSP-D mice off Dox (SP-D off) had increased lung fibrosis compared with mice on Dox (SP-D on). SP-D deficiency also increased macrophage-dominant cell infiltration and the expression of profibrotic cytokines (transforming growth factor [TGF]-β1, platelet-derived growth factor-AA). Alveolar macrophages isolated from BLM-treated iSP-D mice off Dox (SP-D off) secreted more TGF-β1. Fibrocytes, which are bone marrow-derived mesenchymal progenitor cells, were increased to a greater extent in the lungs of the BLM-treated iSP-D mice off Dox (SP-D off). Fibrocytes isolated from BLM-treated iSP-D mice off Dox (SP-D off) expressed more of the profibrotic cytokine TGF-β1 and more CXCR4, a chemokine receptor that is important in fibrocyte migration into the lungs. Exogenous SP-D administered intratracheally attenuated BLM-induced lung fibrosis in SP-D(-/-) mice.

Conclusions: These data suggest that alveolar SP-D regulates numbers of macrophages and fibrocytes in the lungs, profibrotic cytokine expression, and fibrotic lung remodeling in response to BLM injury.

Citing Articles

Serum surfactant protein D as a significant biomarker for predicting occurrence, progression, acute exacerbation, and mortality in interstitial lung disease: a systematic review and meta-analysis.

He X, Ji J, Zheng D, Luo Z, Luo L, Guo L Front Immunol. 2025; 16:1450798.

PMID: 40028331 PMC: 11868069. DOI: 10.3389/fimmu.2025.1450798.


Lung cell transplantation for pulmonary fibrosis.

Milman Krentsis I, Zheng Y, Rosen C, Shin S, Blagdon C, Shoshan E Sci Adv. 2024; 10(34):eadk2524.

PMID: 39178253 PMC: 11343030. DOI: 10.1126/sciadv.adk2524.


Club Cells-A Guardian against Occupational Hazards.

Otelea M, Oancea C, Reisz D, Vaida M, Maftei A, Popescu F Biomedicines. 2024; 12(1).

PMID: 38255185 PMC: 10813369. DOI: 10.3390/biomedicines12010078.


Abhd2, a Candidate Gene Regulating Airway Remodeling in COPD via TGF-β.

Lv M, Jin L, Sang X, Shi W, Qiang L, Lin Q Int J Chron Obstruct Pulmon Dis. 2024; 19:33-50.

PMID: 38197032 PMC: 10775803. DOI: 10.2147/COPD.S440200.


SSC-ILD mouse model induced by osmotic minipump delivered bleomycin: effect of Nintedanib.

Ravanetti F, Ferrini E, Ragionieri L, Khalajzeyqami Z, Nicastro M, Ridwan Y Sci Rep. 2021; 11(1):18513.

PMID: 34531421 PMC: 8445948. DOI: 10.1038/s41598-021-97728-z.


References
1.
Ikegami M, Na C, Korfhagen T, Whitsett J . Surfactant protein D influences surfactant ultrastructure and uptake by alveolar type II cells. Am J Physiol Lung Cell Mol Physiol. 2004; 288(3):L552-61. DOI: 10.1152/ajplung.00142.2004. View

2.
Wright J . Immunoregulatory functions of surfactant proteins. Nat Rev Immunol. 2005; 5(1):58-68. DOI: 10.1038/nri1528. View

3.
Yang L, Scott P, Giuffre J, Shankowsky H, Ghahary A, Tredget E . Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Lab Invest. 2002; 82(9):1183-92. DOI: 10.1097/01.lab.0000027841.50269.61. View

4.
Botas C, Poulain F, Akiyama J, Brown C, Allen L, GOERKE J . Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D. Proc Natl Acad Sci U S A. 1998; 95(20):11869-74. PMC: 21732. DOI: 10.1073/pnas.95.20.11869. View

5.
Yaekashiwa M, Nakayama S, Ohnuma K, Sakai T, Abe T, Satoh K . Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin. A morphologic study. Am J Respir Crit Care Med. 1997; 156(6):1937-44. DOI: 10.1164/ajrccm.156.6.9611057. View